Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
Pancreatic cancer (PC) is an aggressive, complicated cancer. My experience as a long-term cancer survivor and cancer coach is that PC patients must build on conventional oncology for better, longer lives. Let me explain.
The studies linked and excerpted below explain that:
Though these points may seem obvious to you as you read this post, it is important to point out that the second article below also states that pancreatic cancer patients “Although the study shows better care at high-volume surgical centers for patients with pancreatic or thyroid cancer, few patients travel for their cancer operations, it concludes.”
Pancreatic cancer patients must think outside the box because five-year survival rates for PC are dismal. By “outside the box” I mean that you should consider combining evidence-based, non-conventional therapies with a conventional therapy such as surgery for PC. Examples would be evidence-based integrative therapies to enhance conventional chemotherapy- before or after surgery to remove the PC tumor.
Or Prehabilitation to enhance surgical outcomes. My point is that you must learn and consider all therapy tools at your disposal.
Please take a moment to watch the short video below in order to learn more about some of these therapies:
Have you been diagnosed with pancreatic cancer? What stage? Scroll down the page, post a question or comment and I will reply to you ASAP.
“Most patients with pancreatic carcinoma (85%) will present with obstructive jaundice. The presence of toxic substances as bilirubin and bile salts, impaired liver function and altered nutritional status due to obstructive jaundice have been characterized as factors for the development of complications after surgery..
Whereas PBD was to yield beneficial effects in the experimental setting, conflicting results have been observed in clinical studies. The meta-analysis of relative older studies as well as more importantly a recent clinical trial showed that PBD should not be performed routinely…
PBD for patients with a distal biliary obstruction is leading to more serious complications compared with early surgery. Arguments for PBD have shifted from a potential therapeutic benefit towards a logistic problem such as patients suffering from cholangitis and severe jaundice at admission or patients who need extra diagnostic tests, or delay in surgery due to a referral pattern or waiting list for surgery as well as candidates for neoadjuvant chemo(radio)therapy…
If drainage is indicated in these patients it should be performed with a metal stent to reduce complications after the drainage procedure such as stent occlusion and cholangitis. Considering a change towards more neoadjuvant therapy regimes improvement of the quality of the biliary drainage concept is still important.”
“New study findings link traveling to an academic medical center for surgical removal of pancreatic or thyroid cancer with higher quality surgical care for both cancers. Although the study shows better care at high-volume surgical centers for patients with pancreatic or thyroid cancer,